Microfluidics-imaging platform detects cancer growth signalling in minute biopsy samples

Inappropriate growth and survival signalling, which leads to the aberrant growth of cancer cells, is a driving force behind tumours. Much of current cancer research focuses on the kinase enzymes whose mutations are responsible for such disregulated signalling, and many successful molecularly targeted anti-cancer therapeutics are directed at inhibiting kinase activity...

Read the whole article on

More from